New Clinical Trial for ASPIRE-FTD Commences at Ohio State University Wexner Medical Center

Learn about the new ASPIRE-FTD clinical trial at The Ohio State University Wexner Medical Center, a groundbreaking initiative in the field of frontotemporal dementia research. This trial offers hope for more effective treatments for individuals living with FTD, showcasing the medical center’s commitment to advancing neurology and improving patient outcomes.